Dow Up1.31% Nasdaq Up2.40%

Galectin Therapeutics, Inc. (GALT)

-NasdaqCM
5.09 0.03(0.59%)
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue -   -   -  
Cost of Revenue -   -   -  
Gross Profit -   -   -  
Operating Expenses
Research Development5,688  4,527  3,552  
Selling General and Administrative6,416  5,372  6,857  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (12,104) (9,899) (10,409)
Income from Continuing Operations
Total Other Income/Expenses Net16  224  (506)
Earnings Before Interest And Taxes(12,088)(9,675)(10,915)
Interest Expense -   -   -  
Income Before Tax(12,088)(9,675)(10,915)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(12,088)(9,675)(10,915)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (12,088) (9,675) (10,915)
Preferred Stock And Other Adjustments(9,859)(1,206)(1,798)
Net Income Applicable To Common Shares (21,947) (10,881) (12,713)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.